Arphra/Issuer/UTHR

UTHR

United Therapeutics Corporation

HealthcareBiotechnologyUSUSD

$554.39

LiveJun 01, 2026

AI Brief

Market cap

$23.53B

52w range

272.12 – 609.35

P / E

—

EPS

—

Volume

25.04K

Revenue · FY

—

Explain this page

Arphra AIPlain-English read on United Therapeutics Corporation’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Insider · 30d

Bought

0 txns

Sold

$2.47M

10 txns

Net flow

−$2.47M

Full history →

Price

DB · prices_daily

1M 6M 1Y 5Y

No price history in prices_daily for UTHR.

Peers

No peer list available for UTHR.

Price change · trailing returns

Live

1D	5D	1M	3M	6M	YTD	1Y	3Y	5Y	10Y	Max
-0.79%	-4.55%	-3.15%	+9.63%	+15.10%	+13.37%	+69.72%	+158.76%	+210.66%	+363.74%	+8965.18%

Aftermarket

Live

Jun 01, 01:52 PM

Last trade

$552.41

1 sh

Bid

$552.35

5 sh

Ask

$554.55

2 sh

Spread

$2.200

Sector & industry today

Live

Sectors

Technology
+0.21%
Basic Materials
+0.15%
Financial Services
-0.43%
Industrials
-0.48%
Energy
-0.58%
Consumer Defensive
-0.79%
Consumer Cyclical
-0.85%
Real Estate
-0.98%
Healthcare
-1.37%
Communication Services
-1.47%
Utilities
-2.07%

Top industries (issuer's industry highlighted)

Biotechnology
+0.06%
Software - Infrastructure
+6.80%
Coal
-6.27%
Information Technology Services
+6.00%
Medical - Healthcare Information Services
+5.23%
Other Precious Metals
+3.84%
Broadcasting
-3.48%
Silver
+2.89%
Renewable Utilities
-2.75%
Software - Application
+2.71%
Travel Lodging
-2.70%
Internet Content & Information
-2.61%

Fair value

Football field →

Weighted blend

—

— vs spot

Recommendation

n/a

0 of 0 methods

Method spread

0bull0bear

±5% threshold

Analyst PT consensus: $636.83 (+14.87%)

Total assets

—

Total debt

—

Cash & equiv

—

Operating CF

—

Free cash flow

—

Buybacks

—

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Recent insiders

All →

Insider	Action	Shares	Value	Date
ROTHBLATT MARTINE A director, officer: Chairperson & CEO	Sell	56	$32.67K	May 12, 2026
ROTHBLATT MARTINE A director, officer: Chairperson & CEO	Sell	106	$60.6K	May 12, 2026
ROTHBLATT MARTINE A director, officer: Chairperson & CEO	Sell	240	$136.52K	May 12, 2026
ROTHBLATT MARTINE A director, officer: Chairperson & CEO	Sell	293	$167.92K	May 12, 2026
ROTHBLATT MARTINE A director, officer: Chairperson & CEO	Sell	400	$228.13K	May 12, 2026
ROTHBLATT MARTINE A director, officer: Chairperson & CEO	Sell	401	$230.05K	May 12, 2026

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin